Increased nitric oxide production in patients with systemic sclerosis

Archana Sud, Madhu Khullar, Ajay Wanchu, Pradeep Bambery

Research output: Contribution to journalArticlepeer-review

37 Scopus citations


Nitric oxide (NO, nitrogen monoxide) is a messenger molecule whose synthesis can be induced by proinflammatory cytokines. Increased production of NO has been reported in various inflammatory and autoimmune diseases. We studied serum nitrite and citrulline as surrogate markers for NO production in patients with systemic sclerosis (SSc) and looked for correlation with extent of disease, disease duration, age, and systemic involvement. Thirty-four patients were studied against 20 controls. The nitrite levels were significantly higher in the disease group (1588.4 ± 998.2 nmol/ml compared to 327.8 ± 137.7 nmol/ml; P < 0.001). The citrulline levels of the disease group were also significantly higher (5490.1 ± 2518.3 nmol/ml compared to 3264.5 ± 2509.7 nmol/ml in the controls; P = 0.005). There was no significant difference among limited and diffuse subgroups. There was no significant difference in patients with or without arthritis or interstitial lung disease or with other systemic involvement. On multivariate analysis there was a trend toward a rising level of nitrite with worsening lung functions (P = 0.07). Hence, there is evidence of increased NO production in patients with SSc. There is no difference between NO levels in disease subgroups or those with systemic involvement.

Original languageEnglish (US)
Pages (from-to)615-619
Number of pages5
JournalNitric Oxide - Biology and Chemistry
Issue number6
StatePublished - 2000


  • Progressive systemic sclerosis
  • Reactive nitrogen inter-mediates
  • Scleroderma

ASJC Scopus subject areas

  • Biochemistry
  • Physiology
  • Clinical Biochemistry
  • Cancer Research


Dive into the research topics of 'Increased nitric oxide production in patients with systemic sclerosis'. Together they form a unique fingerprint.

Cite this